The Valley Desk

PreprintResearch SquarePublished

A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the publisher record name Fox Chase Cancer Center, University of Pennsylvania, The Wistar Institute, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Preprint
Venue
Research Square
Published
PubMed ID
42996136
PubMed Central ID
PMC13738933
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal